Document is current
Any future updates will be listed below
-
Authors
Panozzo, Catherine A.
Walsh, Edward E.
Yang, Zhen
Wilson, Eleanor
Goswami, Jaya
Stoszek, Sonia K.
Loback, Adrianna
Ng, Tony
Francis, Beverly M.
Simorellis, Alana K.
Huang, Wenmei
Li, Linwei
Vislay-Wade, Rebecca
Zheng, Zhe
Anderson, Evan J.
August, Allison
Chen, Grace
Falsey, Ann R.
-
Funding
Funding for this research was provided by:
Moderna
- License Information
-
More Information
Article History
Received: 26 June 2024
Accepted: 25 October 2024
First Online: 16 November 2024
Declarations
:
: Catherine A. Panozzo, Zhen Yang, Eleanor Wilson, Jaya Goswami, Sonia K. Stoszek, Beverly M. Francis, Alana K. Simorellis, Wenmei Huang, Linwei Li, Evan J. Anderson, Rebecca Vislay-Wade, and Zhe Zheng are employees of Moderna, Inc., and hold stock/stock options in the company. Adrianna Loback, Tony Ng, Allison August, and Grace Chen. were employees of Moderna, Inc., at the time of study conduct. Ann R. Falsey has received research grants from Pfizer, Janssen, Merck, CyanVac, BioFire Diagnostics, and Vaccine Company; has consulted for Sanofi Pasteur and Arrowhead Pharmaceuticals; and has received payment from Novavax DSMB. Edward E. Walsh has received research grants from Pfizer and Merck and has served on the advisory board for GSK and Moderna, Inc.
: This study involved secondary use of de-identified data that had previously received Institutional Review Board approval. As such, additional ethics approval was not required, and informed consent was not applicable.
